About Symposium

ABOUT THE SYMPOSIUM

ENA 2022 is the drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.

Attracting academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.

REASONS TO PARTICIPATE

reasons to participate
reasons to participate
1. ENA is at the forefront of cancer drug development
2. presentation of ground-breaking new data
3. Networking opportunities with world leading experts

4. Influencing future presentation of ground-breaking new data

OUR SPEAKERS

With a truly wide-ranging scientific programme, the ENA 2022 Symposium brings together over 80 top experts in all fields of drug development and translational research from Europe and around the world.

Take a look at some of the first confirmed speakers.

OUR SPEAKERS

With a truly wide-ranging scientific programme, the ENA 2022 Symposium brings together over 80 top experts in all fields of drug development and translational research from Europe and around the world.

Take a look at some of the first confirmed speakers.

KEY DATES

Don’t want to miss any important key dates for ENA?

Plan ahead and add all the key dates for the conference into your diary. Ensuring you don’t miss out on any deadlines.

scientist with microscope

KEY DATES

Don’t want to miss any important key dates for ENA?

Plan ahead and add all the key dates for the conference into your diary. Ensuring you don’t miss out on any deadlines.

scientist with microscope

Subscribe to our e-alerts

    to the privacy policy

    Subscribe to our e-alerts

      to theprivacy policy

      Would you like to stay up to date with our news?

        to theprivacy policy

        EORTC logo
        NIH
        AACR